AccessHope

What AccessHope does

AccessHope is a B2B cancer care benefits platform that connects employees of self-insured employers and health plan members with expert oncology opinions from NCI-Designated Comprehensive Cancer Centers. Founded in 2020 as a wholly owned subsidiary of City of Hope and spun out as a standalone commercial entity in April 2024, the company contracts with employers (and indirectly through channel partners such as WebTPA, Employer Direct Healthcare, Lantern, and Carrum Health) to provide a cancer benefit that automatically routes the most clinically complex cases to a 330+ subspecialist network spanning seven NCI-Designated centers including City of Hope, Dana-Farber, Northwestern/Lurie, Emory/Winship, Fred Hutch, Johns Hopkins/Kimmel, and UT Southwestern/Simmons.

The core technology stack is a remote expert oncology consultation platform built on a proprietary Accountable Precision Oncology algorithm that uses ICD-10 and Rx condition triggers to identify the top 20% of cancers most vulnerable to care mismatch and route them to subspecialist review. The product suite comprises four main services: Accountable Precision Oncology (algorithmic case identification), Expert Advisory Review (subspecialist recommendations to the treating community oncologist), Cancer Support Team (oncology nurse navigation), and Expert Evaluation (in-person center evaluations). A Clinical Trial Enrollment Service built on Trial Library technology launched in October 2025. The platform is HITRUST r2 and SOC 2 Type I certified and operates as a HIPAA-compliant infrastructure for health information exchange.

The business model is enterprise B2B subscription revenue — likely per-member-per-month or per-covered-life pricing negotiated with employers, health plans, TPAs, and benefits administrators — with go-to-market executed through a field sales team targeting HR and benefits professionals, supplemented by an expanding channel network of TPAs, specialty care platforms, and benefits consultants. The company serves 800+ organizations including 80+ Fortune 500 employers and supports 10M+ members nationwide as of March 2026, with reported outcomes including a 3:1 employer ROI, $19,000+ average savings per patient when recommendations are adopted, and a Net Promoter Score of 79.

Name

AccessHope

Legal name

AccessHope, LLC

Website

https://myaccesshope.org

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

101–250 employees

Short description

AccessHope is a B2B cancer care benefits platform connecting self-insured employers and health plan members with remote expert oncology opinions from a 330+ subspecialist network spanning seven NCI-Designated Comprehensive Cancer Centers, using a proprietary algorithm to route complex cases.

Ownership category

akta.pro rank

Headquarters

HQ city

Duarte

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Employer-Sponsored Cancer Benefit: AccessHope provides cancer care benefits to self-insured employers as an employee benefit. Employers pay for the service as part of their health benefits package to cover employees and their families. This is the primary revenue stream, with employers paying based on the number of covered lives.
2. Health Plan Partnerships: AccessHope partners with health plans to provide expert oncology reviews for their members. Health plans integrate AccessHope services into their oncology care management offerings.
3. Third-Party Administrator Channel: AccessHope extends services through TPAs and benefits administrators who offer AccessHope's cancer care solutions to their self-insured employer clients.

Go-to-market motion1 record

Distribution channels5 records

Marketing channels8 records

Core offering

AccessHope provides employer-sponsored cancer care benefits by remotely connecting community oncologists and their patients with subspecialty experts from NCI-Designated Comprehensive Cancer Centers. The company delivers expert case reviews, treatment recommendations, oncology nurse support, and clinical trial matching as part of self-insured employer health benefit programs, health plan offerings, and through channel partners such as TPAs and health technology platforms.

Product overview

AccessHope is a cancer care benefits platform that provides automatic, equitable access to leading-edge cancer expertise through partnerships with NCI-Designated Comprehensive Cancer Centers. The core platform consists of four main services: Accountable Precision Oncology (algorithmic case identification and routing), Expert Advisory Review (subspecialist treatment recommendations), Cancer Support Team (oncology nurse support), and Expert Evaluation (in-person center evaluations). Additional services include Clinical Trial Enrollment support. The platform connects local oncologists with subspecialists so patients can receive advanced care without leaving their community.

Differentiator

Problem solved

Functional benefit

Products and services

• Accountable Precision Oncology A program that uses proprietary algorithms with ICD-10 and Rx condition triggers to identify and route complex cancer cases to NCI-Designated Comprehensive Cancer Center subspecialists for expert review, targeting the top 20% of cancers most vulnerable to care mismatches. Sold to self-insured employers as a cancer benefit.
• Expert Advisory Review Subspecialist oncologists review medical records and treatment plans to provide evidence-based recommendations to members' treating oncologists, aligning treatment with the latest research and clinical guidelines. Sold to self-insured employers and health plan members as a cancer benefit.
• Cancer Support Team A dedicated phone line staffed by experienced oncology nurses who provide guidance on preparing for doctor appointments, treatment information, and emotional support throughout the cancer journey. Sold as part of employer-sponsored cancer benefits.
• Expert Evaluation In-person evaluation service at NCI-Designated Comprehensive Cancer Centers where patients are paired with oncologists specializing in their specific cancer type, with consultations with additional specialists as needed. Sold as a benefit to employer health plans and members.
• Clinical Trial Enrollment Service A service utilizing Trial Library technology to match cancer patients to appropriate clinical trials and guide them through enrollment, overcoming barriers faced by community oncologists. Sold to employer clients and health plan partners.

Quantifiable outcome

• 93% of cancer cases receive recommendations for treatment improvements
• +5 more outcomes

Named customers10 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

Feature3 records

Partnerships

16 partnerships are on record, tiered core, foundational and supporting.

• LanterncoreChannel Partner/ Reseller/ Distributor · 11 February 2026Specialty care company expanded its cancer care navigation platform with AccessHope's expert reviews from NCI-designated cancer centers for adult and pediatric cancers, solid tumors, and blood-based diseases. Targets 12 million members.
• Trial LibrarycoreTechnology or Integration · 15 October 2025AccessHope launched a new clinical trial enrollment service utilizing technology from Trial Library to facilitate matching cancer patients to appropriate clinical studies, overcoming barriers faced by community oncologists.
• WebTPAcoreChannel Partner/ Reseller/ Distributor · 15 October 2024Healthcare benefits administrator with 30+ years of experience serving over 3.1 million members extends AccessHope's cancer care services to self-insured employers through its platform.
• Johns Hopkins Medicine (Sidney Kimmel Comprehensive Cancer Center)foundationalStrategic or Co-development Partner · 19 September 2023Johns Hopkins Kimmel Cancer Center joins as sixth NCI-designated comprehensive cancer center partner. Nationally recognized oncologists provide expert case reviews to optimize access to targeted and effective cancer treatment, extending reach in the Mid-Atlantic region.
• Carrum HealthcoreChannel Partner/ Reseller/ Distributor · 2 November 2022Digital health company connecting employers and employees to Centers of Excellence through value-based care platform adds AccessHope's cancer expertise to its comprehensive oncology offering for national distribution.
• Fred Hutchinson Cancer CenterfoundationalStrategic or Co-development Partner · 21 September 2022Fred Hutch becomes AccessHope's fifth collaboration with an NCI-designated cancer center. Specialists from Seattle-based Fred Hutch provide specialized cancer expertise across the Northwestern United States, with expertise in bone marrow transplantation, immunotherapy, and clinical trials.
• Emory Healthcare (Winship Cancer Institute of Emory University)foundationalStrategic or Co-development Partner · 11 January 2022Georgia's only NCI-Designated Comprehensive Cancer Center joins AccessHope's network. Winship specialists provide expert cancer support for southeastern states including Alabama, Florida, Georgia, Mississippi, North Carolina, South Carolina, and Tennessee.
• Employer Direct HealthcarecoreChannel Partner/ Reseller/ Distributor · 5 October 2021Leader in healthcare solutions for self-funded employers selected AccessHope to enhance its comprehensive oncology offering, providing cancer expertise to approximately 6 million people and over 600 employers.
• Dana-Farber Cancer InstitutefoundationalStrategic or Co-development Partner · 29 June 2021Foundational partnership bringing Dana-Farber's renowned cancer expertise to AccessHope's network. Dana-Farber specialists provide tumor type-specific expertise for Accountable Precision Oncology, Expert Advisory Review, and Cancer Support Team services, particularly benefiting Northeast states.
• GRAILsupportingTechnology or Integration · 16 March 2021GRAIL collaborated with AccessHope to optimize patient and provider experience for the Galleri multi-cancer early detection blood test. AccessHope provides coordination services and physician support for positive test results.
• Northwestern Medicine (Robert H. Lurie Comprehensive Cancer Center)foundationalStrategic or Co-development Partner · 18 November 2020Collaboration of two NCI-designated comprehensive cancer centers enabling remote delivery of Northwestern Medicine's world-renowned cancer expertise to employers, patients, and treating oncologists nationwide. Specialists provide case review and treatment recommendations.
• City of HopefoundationalStrategic or Co-development Partner · 6 October 2020City of Hope is AccessHope's founding parent company and primary NCI-designated comprehensive cancer center partner. City of Hope invested over $40 million in AccessHope and provides access to world-renowned cancer expertise. AccessHope was spun out as a standalone commercial entity in spring 2024, but maintains close strategic partnership with City of Hope.
• Quantum HealthcoreStrategic or Co-development Partner · 6 March 2018Early partnership with Quantum Health, the market leader in consumer navigation and care coordination. Quantum Health's Personal Precision Oncology Management program leverages City of Hope/AccessHope cancer expertise for employer clients.
• UT Southwestern Medical Center (Harold C. Simmons Comprehensive Cancer Center)foundationalStrategic or Co-development PartnerUT Southwestern's Harold C. Simmons Comprehensive Cancer Center is listed as a foundational partner, expanding AccessHope's network to include Texas and the Southwest region.
• Health Transformation AlliancesupportingChannel Partner/ Reseller/ DistributorCollaborative relationship with Health Transformation Alliance, a coalition of self-insured employers transforming healthcare delivery.
• Collective HealthsupportingChannel Partner/ Reseller/ DistributorPartnership with Collective Health through its Premier Partner Program to extend AccessHope's cancer care services to Collective Health's employer clients.

Scale indicators10 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Transcarent: Employer-facing healthcare platform offering specialty care access, virtual visits, and care navigation on a single benefit. Closely comparable to AccessHope in B2B employer-channel GTM and specialty care focus, though Transcarent spans multiple conditions rather than specializing in oncology.
• Lantern: Specialty care platform providing cancer care navigation and Centers of Excellence to self-funded employers. Direct competitor in cancer-care navigation, and also a channel partner that embeds AccessHope's NCI expert reviews.
• Carrum Health: Value-based Centers of Excellence platform for self-insured employers, with a core oncology offering. Overlaps with AccessHope in providing cancer care benefits to employer clients and is both a partner and a competitor in the COE space.
• Employer Direct Healthcare: Healthcare solutions provider for self-funded employers including cancer care, surgery, and advanced care offerings. Both a channel reseller of AccessHope and a peer competing for similar employer oncology benefit budgets.
• Quantum Health: Market-leading consumer navigation and care coordination platform for self-insured employers. Operates the Personal Precision Oncology Management program that integrates AccessHope - comparable in GTM (employers/benefits teams) and adjacent in oncology navigation.

Broad incumbents

• Accolade: Personalized healthcare advocacy and navigation platform serving large employers and health plans, including acquired 2nd.MD expert medical opinion services. Comparable buyer segment (HR/benefits) and broader navigation capabilities versus AccessHope's oncology specialization.
• Included Health: Virtual primary care, specialty care, and care navigation platform serving employers and health plans. Overlaps with AccessHope in employer-channel delivery of specialty expertise but across a broader clinical scope.

Emerging players

• Centivo: Self-funded employer health plan administrator focused on value-based care delivery. Comparable GTM (self-insured employers, HR/benefits buyers) with integrated specialty networks; intersects with AccessHope where it offers oncology solutions.
• Hinge Health: Digital musculoskeletal care and virtual specialist platform for employers and health plans. Comparable B2B benefits model and target buyer (HR leaders) with similar employer-channel distribution, though focused on MSK rather than oncology.

Others

• Collective Health: Self-funded employer health benefits platform that operates a Premier Partner Program through which AccessHope distributes services. Comparable employer buyer segment and distribution channel; functions more as partner than direct competitor but addresses the same benefits budget.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/myaccesshope
• LinkedInlinkedin.com/company/accesshope

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AccessHope